IRB Seminar - Klaus Früh, VGTI-Vaccine and Gene Therapy Institute, Oregon Health & Science University, OR, USA
Istituto di ricerca in biomedicina
Data: 19 Febbraio 2018 / 12:00 - 13:00
Prof. Klaus Früh
“New Vaccine Strategies using cytomegalovirus"
VGTI-Vaccine and Gene Therapy Institute, Molecular and Cellular Biosciences, School of Medicine, Oregon Health & Science University, OR, United States
Monday, February 19th, 2018 at 12.00
IRB Conference Room
Institute for Research in Biomedicine (IRB)
Via Vincenzo Vela 6
CH-6500 Bellinzona
